|
|
Volumn 17, Issue 7, 2002, Pages 1304-1309
|
|
Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation
a
|
|
Author keywords
ALG; Basiliximab; Paediatric renal transplantation
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
HLA ANTIGEN;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LYMPHOCYTE ANTIBODY;
PREDNISOLONE;
TACROLIMUS;
BASILIXIMAB;
CYCLOSPORIN;
HYBRID PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
ADOLESCENT;
AGE;
ARTICLE;
BODY SIZE;
CHILD;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DEATH;
DRUG EFFICACY;
FEMALE;
GLOMERULUS FILTRATION RATE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HLA MATCHING;
HUMAN;
IMMUNOPROPHYLAXIS;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY BIOPSY;
KIDNEY FAILURE;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
MEDICAL DOCUMENTATION;
PNEUMOCYSTIS CARINII;
PNEUMOCYSTIS PNEUMONIA;
POSTOPERATIVE PERIOD;
PRESCRIPTION;
PRIORITY JOURNAL;
REOPERATION;
RISK ASSESSMENT;
THROMBOSIS;
TREATMENT OUTCOME;
ALLOTRANSPLANTATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DRUG COMBINATION;
DRUG EFFECT;
FOLLOW UP;
IMMUNOLOGY;
POSTOPERATIVE COMPLICATION;
TIME;
ANTIBODIES, MONOCLONAL;
ANTILYMPHOCYTE SERUM;
AZATHIOPRINE;
CHILD;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
POSTOPERATIVE COMPLICATIONS;
PREDNISOLONE;
RECOMBINANT FUSION PROTEINS;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
|
EID: 0036020929
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/17.7.1304 Document Type: Article |
|
Times cited : (31)
|
|
References (11)
|
